• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6-氯-2-芳基-1H-咪唑并[4,5-b]吡啶衍生物的合成:抗糖尿病、抗氧化、β-葡萄糖醛酸酶抑制作用及其分子对接研究。

Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies.

作者信息

Taha Muhammad, Ismail Nor Hadiani, Imran Syahrul, Rashwan Hesham, Jamil Waqas, Ali Sajjad, Kashif Syed Muhammad, Rahim Fazal, Salar Uzma, Khan Khalid Mohammed

机构信息

Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia; Faculty of Applied Science UiTM, 40450 Shah Alam, Selangor, Malaysia.

Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor, Malaysia; Faculty of Applied Science UiTM, 40450 Shah Alam, Selangor, Malaysia.

出版信息

Bioorg Chem. 2016 Apr;65:48-56. doi: 10.1016/j.bioorg.2016.01.007. Epub 2016 Feb 1.

DOI:10.1016/j.bioorg.2016.01.007
PMID:26855413
Abstract

6-Chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives 1-26 were synthesized and characterized by various spectroscopic techniques. All these derivatives were evaluated for their antiglycation, antioxidant and β-glucuronidase potential followed their docking studies. In antiglycation assay, compound 2 (IC50=240.10±2.50μM) and 4 (IC50=240.30±2.90μM) was found to be most active compound of this series, while compounds 3 (IC50=260.10±2.50μM), 6 (IC50=290.60±3.60μM), 13 (IC50=288.20±3.00μM) and 26 (IC50=292.10±3.20μM) also showed better activities than the standard rutin (IC50=294.50±1.50μM). In antioxidant assay, compound 1 (IC50=69.45±0.25μM), 2 (IC50=58.10±2.50μM), 3 (IC50=74.25±1.10μM), and 4 (IC50=72.50±3.30μM) showed good activities. In β-glucuronidase activity, compounds 3 (IC50=29.25±0.50μM), compound 1 (IC50=30.10±0.60μM) and compound 4 (IC50=46.10±1.10μM) showed a significant activity as compared to than standard D-Saccharic acid 1,4-lactonec (IC50=48.50±1.25μM) and their interaction with the enzyme was confirm by docking studies.

摘要

合成了6-氯-2-芳基-1H-咪唑并[4,5-b]吡啶衍生物1-26,并通过各种光谱技术对其进行了表征。对所有这些衍生物进行了抗糖化、抗氧化和β-葡萄糖醛酸酶活性评估,并随后进行了对接研究。在抗糖化试验中,发现化合物2(IC50=240.10±2.50μM)和4(IC50=240.30±2.90μM)是该系列中活性最高的化合物,而化合物3(IC50=260.10±2.50μM)、6(IC50=290.60±3.60μM)、13(IC50=288.20±3.00μM)和26(IC50=292.10±3.20μM)的活性也优于标准芦丁(IC50=294.50±1.50μM)。在抗氧化试验中,化合物1(IC50=69.45±0.25μM)、2(IC50=58.10±2.50μM)、3(IC50=74.25±1.10μM)和4(IC50=72.50±3.30μM)表现出良好的活性。在β-葡萄糖醛酸酶活性方面,与标准D-糖二酸1,4-内酯(IC50=48.50±1.25μM)相比,化合物3(IC50=29.25±0.50μM)、化合物1(IC50=30.10±0.60μM)和化合物4(IC50=46.10±1.10μM)表现出显著活性,并且通过对接研究证实了它们与该酶的相互作用。

相似文献

1
Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies.6-氯-2-芳基-1H-咪唑并[4,5-b]吡啶衍生物的合成:抗糖尿病、抗氧化、β-葡萄糖醛酸酶抑制作用及其分子对接研究。
Bioorg Chem. 2016 Apr;65:48-56. doi: 10.1016/j.bioorg.2016.01.007. Epub 2016 Feb 1.
2
Synthesis, β-glucuronidase inhibition and molecular docking studies of hybrid bisindole-thiosemicarbazides analogs.杂合双吲哚-硫代氨基脲类似物的合成、β-葡萄糖醛酸酶抑制及分子对接研究
Bioorg Chem. 2016 Oct;68:56-63. doi: 10.1016/j.bioorg.2016.07.008. Epub 2016 Jul 18.
3
Thiadiazole derivatives as New Class of β-glucuronidase inhibitors.噻二唑衍生物作为新型β-葡萄糖醛酸酶抑制剂
Bioorg Med Chem. 2016 Apr 15;24(8):1909-18. doi: 10.1016/j.bmc.2016.03.020. Epub 2016 Mar 10.
4
Synthesis of pyrimidine-2,4,6-trione derivatives: Anti-oxidant, anti-cancer, α-glucosidase, β-glucuronidase inhibition and their molecular docking studies.嘧啶-2,4,6-三酮衍生物的合成:抗氧化、抗癌、α-葡萄糖苷酶、β-葡萄糖醛酸酶抑制作用及其分子对接研究。
Bioorg Chem. 2016 Oct;68:72-9. doi: 10.1016/j.bioorg.2016.07.009. Epub 2016 Jul 19.
5
Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines.喹啉的合成、体外β-葡萄糖醛酸酶抑制潜力及分子对接研究
Eur J Med Chem. 2017 Oct 20;139:849-864. doi: 10.1016/j.ejmech.2017.08.052. Epub 2017 Aug 24.
6
Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies.双吲哚作为强效β-葡萄糖醛酸酶抑制剂的评估:合成及基于计算机模拟的研究
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1825-9. doi: 10.1016/j.bmcl.2014.02.015. Epub 2014 Feb 14.
7
Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies.双吲哚甲烷作为新型β-葡萄糖醛酸酶潜在抑制剂的合成及其分子对接研究
Eur J Med Chem. 2018 Jan 1;143:1757-1767. doi: 10.1016/j.ejmech.2017.10.071. Epub 2017 Oct 26.
8
Dihydropyrimidones: As novel class of β-glucuronidase inhibitors.二氢嘧啶酮:作为一类新型的β-葡萄糖醛酸酶抑制剂。
Bioorg Med Chem. 2016 Aug 15;24(16):3624-35. doi: 10.1016/j.bmc.2016.06.002. Epub 2016 Jun 4.
9
Synthesis: Small library of hybrid scaffolds of benzothiazole having hydrazone and evaluation of their β-glucuronidase activity.合成:具有腙和苯并噻唑的混合支架的小文库及其β-葡萄糖醛酸酶活性的评价。
Bioorg Chem. 2018 Apr;77:47-55. doi: 10.1016/j.bioorg.2018.01.002. Epub 2018 Jan 4.
10
Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors.合成苯并咪唑衍生物作为有效的β-葡萄糖醛酸酶抑制剂。
Bioorg Chem. 2015 Aug;61:36-44. doi: 10.1016/j.bioorg.2015.05.010. Epub 2015 Jun 4.

引用本文的文献

1
Imidazopyridine Family: Versatile and Promising Heterocyclic Skeletons for Different Applications.咪唑并吡啶家族:适用于不同应用的多功能且有前景的杂环骨架。
Molecules. 2024 Jun 5;29(11):2668. doi: 10.3390/molecules29112668.
2
Biological Activity of Amidino-Substituted Imidazo [4,5-]pyridines.氨甲酰基取代的咪唑并[4,5-]吡啶的生物活性。
Molecules. 2022 Dec 21;28(1):34. doi: 10.3390/molecules28010034.
3
Heterocyclic compounds as a magic bullet for diabetes mellitus: a review.杂环化合物作为糖尿病的神奇疗法:综述
RSC Adv. 2022 Aug 16;12(35):22951-22973. doi: 10.1039/d2ra02697j. eCollection 2022 Aug 10.
4
Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.β-葡萄糖醛酸酶活性及其抑制剂的治疗意义:综述。
Eur J Med Chem. 2020 Feb 1;187:111921. doi: 10.1016/j.ejmech.2019.111921. Epub 2019 Dec 4.
5
Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review.含氯分子的合成方法及其在药物发现中的药物应用: 批判性评价。
Eur J Med Chem. 2019 Jul 1;173:117-153. doi: 10.1016/j.ejmech.2019.03.063. Epub 2019 Apr 10.
6
Synthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole Derivatives.吲哚基噁二唑衍生物的合成、分子对接和β-葡萄糖醛酸酶抑制潜力。
Molecules. 2019 Mar 8;24(5):963. doi: 10.3390/molecules24050963.
7
Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors.6-(4-硝基苯氧基)-1H-咪唑并[4,5-b]吡啶衍生物作为新型抗结核药物的合成、生物学评价及分子对接研究:未来的DprE1抑制剂
Chem Cent J. 2018 Dec 19;12(1):138. doi: 10.1186/s13065-018-0515-1.
8
Crystallographic and spectroscopic characterization of 5-chloro-pyridine-2,3-di-amine.5-氯吡啶-2,3-二胺的晶体学和光谱表征
Acta Crystallogr E Crystallogr Commun. 2017 Jul 21;73(Pt 8):1213-1217. doi: 10.1107/S2056989017010489. eCollection 2017 Jul 1.
9
Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.咪唑并[4,5 - b]吡啶和咪唑并[4,5 - c]吡啶衍生物的药理潜力与合成方法
Molecules. 2017 Mar 4;22(3):399. doi: 10.3390/molecules22030399.